Vertex Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
CEOReshma Kewalramani
CEOReshma Kewalramani
Employees6,100
Employees6,100
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded1989
Founded1989
Employees6,100
Employees6,100
VRTX Key Statistics
Market cap117.99B
Market cap117.99B
Price-Earnings ratio-117.17
Price-Earnings ratio-117.17
Dividend yield—
Dividend yield—
Average volume1.41M
Average volume1.41M
High today$461.05
High today$461.05
Low today$456.58
Low today$456.58
Open price$458.45
Open price$458.45
Volume763.28K
Volume763.28K
52 Week high$519.88
52 Week high$519.88
52 Week low$377.85
52 Week low$377.85
VRTX News
TipRanks 2d
Vertex Pharmaceuticals presents long-term data on CASGEVYVertex Pharmaceuticals (VRTX) recently announced longer-term data for PrCASGEVY from global ongoing pivotal clinical trials in people with severe sickle cell di...
Analyst ratings
53%
of 34 ratingsBuy
52.9%
Hold
41.2%
Sell
5.9%
People also own
Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.